SCHEMBL2987658

SCHEMBL2987658

O=c1cc(-c2ccccc2)c2ccc(O)cc2o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 11/20 1.00
CA12 O43570 10/20 1.00
AKR1B1 P15121 3/20 1.00
MAOB P27338 3/20 1.00
HSD17B3 P37058 3/20 1.00
MAOA P21397 2/20 1.00
ALDH2 P05091 1/20 1.00
SORD Q00796 1/20 1.00
MCL1 Q07820 1/20 0.69
NOD2 Q9HC29 1/20 0.68
LMNA P02545 1/20 0.66
ALDH1A1 P00352 3/20 0.62
KDM4E B2RXH2 2/20 0.62
HPGD P15428 2/20 0.62
MAP1LC3B Q9GZQ8 1/20 0.61
KMT2A Q03164 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.59
AKR1B10 O60218 1/20 0.59
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29736952 1.00 CA9 (1.00) CA9CA12AKR1B1MAOBHSD17B3
Acrylic Acid SCHEMBL29007733 0.90 CA9 (0.82) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL27442679 0.90 CA12 (0.82) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL14424515 0.86 CA12 (0.75) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL5085649 0.86 CA12 (0.75) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL21648248 0.84 CA12 (0.74) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL21648241 0.84 CA12 (1.00) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL21648245 0.84 CA12 (1.00) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL21648244 0.84 CA12 (0.74) CA9CA12AKR1B1MAOBHSD17B3
SCHEMBL29570235 0.84 CA12 (0.74) CA9CA12AKR1B1MAOBHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023215875-A1 PHENOL CONTAINING SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS GLOBAL THERMOSTAT OPERATIONS, LLC. (US) 2023-11-09 WO claimed
CN-107987209-B Coumarin polymer semiconductor laser material and application thereof 无锡佶达德光电子技术有限公司 2023-05-02 CN claimed
CN-107936172-B Preparation method of coumarin polymer semiconductor laser material 无锡佶达德光电子技术有限公司 2023-04-28 CN claimed
CN-108047212-B Preparation method of bispyrazole acetic coumarin derivative laser material 深圳市佶达德科技有限公司 2023-03-10 CN claimed
JP-2191269-A None JP disclosed
CN-121846086-A Medical use of 7-hydroxy-4-phenylcoumarin 上海中医药大学 2026-04-14 CN disclosed
EP-2247558-B2 NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION LILLY CO ELI (US) 2024-07-03 EP disclosed
US-20240100172-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY PAQ Therapeutics Inc. 2024-03-28 US disclosed
US-20240060096-A1 COMPOSITIONS AND METHODS FOR PRODUCING 1,8-DIHYDROXYNAPHTHALENE AND CYCLIC HYDROCARBONS FROM 1,8-DIHYDROXYNAPHTHALENE TECH HOLDING LLC (US) 2024-02-22 US disclosed
WO-2023215875-A1 PHENOL CONTAINING SORBENTS, SYSTEMS INCLUDING SORBENTS, AND METHODS USING THE SORBENTS GLOBAL THERMOSTAT OPERATIONS, LLC. (US) 2023-11-09 WO disclosed
CN-116768837-A Benzopyran-2-one-based fluorescence chemical sensor and preparation method and application thereof 常州大学 2023-09-19 CN disclosed
CN-114349729-B Coumarin derivative and preparation method and application thereof 包头稀土研究院 2023-07-18 CN disclosed
US-5886028-A REDUCING ALCOHOL CONSUMPTION BY ADMINISTERING AN ENZYME INHIBITOR THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) 1999-03-23 US disclosed
US-5624910-A INHIBITING ALDEHYDE DEHYRDOGENASE ACTIVITY USING DAIDZIN THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) 1997-04-29 US disclosed
US-5424320-A Antihistamine, antiallergic, antiinflammatory and cytoprotective agents MERCK FROSST CANADA, INC. (CA) 1995-06-13 US disclosed
US-5360815-A Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis MERCK FROSST CANADA, INC. (CA) 1994-11-01 US disclosed
EP-0592583-A1 METHOD FOR THE INHIBITION OF ALDH-I USEFUL IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ALCOHOL ABUSE THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) 1994-04-20 EP disclosed
US-5204369-A METHOD FOR THE INHIBITION OF ALDH-I USEFUL IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ALCOHOL ABUSE THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY (US) 1993-04-20 US disclosed
WO-1993000896-A1 METHOD FOR THE INHIBITION OF ALDH-I USEFUL IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ALCOHOL ABUSE THE ENDOWMENT FOR RESEARCH IN HUMAN BIOLOGY, INC. (US) 1993-01-21 WO disclosed
JP-H02191269-A 7-CARBOXYMETHOXY-4-PHENYLCUMARIN DERIVATIVE, PRODUCTION THEREOF AND USAGE THEREOF TOYO PHARMA- KK 1990-07-27 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240100172-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, SQSTM1, BECN1 CA9 4753/4885CA12 4772/4885AKR1B1 4307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.